Global Access Evidence Lead

Posted 24 November 2021
SalaryNegotiable
LocationBasel
Job type Limited
DisciplineScienceLife Sciences
ReferenceBBBH496638_1637752774

Job description

For our customer, the world`s leading pharamceutical company in Basel, we are looking for a matrix experienced global health expert with a strong statistical background

Global Access Evidence Lead


Background:
Global Access is focused on delivering sustainable, replicable and scalable global strategies, policies and solutions. Our work aims to support the pharma vision and enables affiliates to drive patient access locally while maximizing the value for society, ecosystems and business. We are operating in a highly networked and agile model with stable chapters and a variety of flexible squads and work product teams along the lifecycle and across disease areas, functions and geographies. Chapters are based on the expertise and capabilities needed to co-create and deliver integrated solutions with our internal and external partners.


As one of the GA Evidence Leads in the Evidence Chapter you will work with colleagues across the global organization (commercial, development, medical affairs) and local market access representatives to develop the HTA Evidence strategies and packages supporting decisions which determine access to company's innovative offerings as well as the evidence needed to support global policy and ecosystem shaping initiatives.

You will cross functionally collaborate to develop the evidence package used by payers and other HTA bodies to support both the pre-launch and launch stage of reimbursement process. You will support the design of pivotal trials and evidence packages, identify access evidence gaps and develop risk mitigation strategies, execute evidence generation plans, and conduct analyses to address molecule and disease area questions to inform access and the broader integrated business. You will also contribute to functional, cross-functional, enterprise-wide strategic alignment and external initiatives that shape our business and healthcare environments including the application of novel methodologies used to support HTA/payer decision making. This requires a strong understanding of integrated access strategies, integrated evidence plans, healthcare environments, affiliate pricing & reimbursement needs, as well as strong scientific and technical expertise.


Tasks & Responsibilities

  • You plan and execute health economic and/or statistical analyses on clinical trial data and other relevant data sources consideration of the input/feedback from affiliates and global colleagues whilst adhering to industry best practices to support access decision making
  • You develop supportive technical documentation of economic and statistical analyses and support interpretation of findings with appropriate communication methods
  • You actively contribute to best practices and continuous improvement within the HTA Evidence Group


Must Haves:

  • Masters minimum or Doctoral level degree in a relevant discipline (MD, PharmD, PhD or MSc in health economics, epidemiology, public health, biostatistic, statistics or life science disciplines - quantitative focus preferred
  • 5 years experience of relevant experience in the field, strong statistical focus and experience in HTA submissions (with NICE, GBA, HAS etc.)
  • Expertise in R necessary and in one of MS Excel (with VBA), SAS, Python, WinBUGS, JAGS or other relevant statistical software
  • Health Economics experience, expertise in conducting network meta-analyses (NMA) and/or the application of evolving methodologies in health economic modelling
  • Extensive knowledge of health technology assessment, clinical research and development methods and international payer evidence requirements


Your Application
Please apply online. For further information about the position, please contact your Kelly consultant, Dr.med. Andreas Danner (+41 44 225 41 07).